National Institute of Neurological Disorders and Stroke - NINDS

03/13/2026

As of March 11, 2026, this account is no longer active.

Please look for our content on the National Institutes of Health (NIH) page and follow along for the latest news and information from NIH!

To continue receiving updates from NINDS, subscribe to our listservs:

- NINDS: https://bit.ly/NINDS-list

- NIH HEAL Initiative: https://bit.ly/4bmWsBM

02/10/2026

Are you subscribed to the NINDS Training Listserv? We post a bi-weekly newsletter with upcoming events, announcements, and resources. Subscribe now to stay informed: https://bit.ly/NINDSTrainingList

02/06/2026

New research in Nature Medicine featuring NINDS funded clinical testing highlights the promise of a more targeted approach to treating myasthenia gravis.

Two complementary studies report that a short course of a novel RNA-based CAR-T cell therapy led to durable clinical improvement in people with generalized myasthenia gravis—without the broad immune suppression often associated with conventional CAR-T treatments. The outpatient therapy was associated with sustained symptom improvement while preserving the protective immune response.

These findings advance our understanding of how precision cell therapies may offer safer, more accessible treatment options for myasthenia gravis and other neurological autoimmune disorders.

https://pubmed.ncbi.nlm.nih.gov/41514038/
https://pubmed.ncbi.nlm.nih.gov/41514039/

02/05/2026

3rd Semi-Annual PURPOSE Meeting

The NIH and the NIH HEAL Initiative are excited to invite you to the third semi-annual PURPOSE Meeting, taking place March 22 & 23, 2026. The PURPOSE meeting offers opportunities for learning, networking, and collaboration for pain researchers across the continuum of basic, translational, and clinical research - and connect them with NIH Program Officers and mentors outside of their home institutions.

This year’s meeting is being held in conjunction with the USASP Early Career Forum, preceding the USASP Annual Meeting in Philadelphia.

When:
- March 22, 2026: Interdisciplinary PAIN Cohort Meeting (T90/R90, T32s, and other trainees)
- March 23, 2026: PURPOSE Annual Meeting & USASP Early Career Forum

Where:
Hybrid – In-person (Loews Philadelphia Hotel) and Online | Registration Required

Learn more: https://painresearchers.com/events/152764

02/04/2026

NINDS is attending the International Stroke Conference from February 4-6 in New Orleans! Stop by the exhibit hall to connect with NINDS staff and learn more about how our work is actively contributing to stroke research and development.

01/28/2026

The next due date for the NIH F30 and F31 predoctoral fellowship applications is April 8. These fellowships provide vital support for doctoral students conducting NIH mission-relevant research.

To help you prepare, explore our NINDS resources and guidance: https://www.ninds.nih.gov/funding/training-career-development/predoctoral-felllows

01/27/2026

https://www.facebook.com/share/p/1AU86cfTCv/

Study provides clearest evidence to date to link severe CTE to dementia risk.

01/23/2026

Did you know? NINDS F32 applications do not require preliminary data! In fact, NINDS strongly discourages preliminary data in the program announcement. Rather, applications should focus on innovative research ideas and thoughtful plans for training and mentorship. The next due date is Feb 9, 2026.

See our NINDS F32 webpage for more information: bit.ly/4mmsiCg

01/22/2026

In April 2024, NINDS brought together stakeholders to evaluate the gap between the current understanding of Parkinson’s disease (PD) and the development of therapeutics for treating PD. The report from the workshop is officially published!

The workshop identified key scientific and translational priorities needed to advance disease-modifying therapies for Parkinson’s disease. Areas of focus may include improving understanding of disease heterogeneity, strengthening biomarker development, refining therapeutic target validation, and best practices for therapeutic development.

This roadmap, for and from the PD community, highlights opportunities to better align research efforts and accelerate progress toward more effective treatments for people living with Parkinson’s disease.

Read the full publication: https://www.nature.com/articles/s41531-025-01154-1

01/21/2026

NINDS clinician-scientist awards provide training and mentoring to enable medical, dental, and veterinary clinicians to develop their research skills.

Awards that offer individual support for the career development of clinically-trained professionals who have made a commitment to research include:

K08 - Mentored Clinical Scientist Research Career Development Award
K23 - Mentored Patient-Oriented Research Career Development Award
K02 - Independent Scientist Award

Institutional awards for clinician-scientist training include:

UE5 - Research Education Programs for Residents & Fellows
K12 - Institutional Career Development Program

Learn more about NINDS Clinician Scientist awards: bit.ly/4mG8slO

Have questions, email: [email protected]

01/16/2026

The National Institute of Neurological Disorders and Stroke (NINDS) invites you to the kick-off of a new Preclinical Common Data Elements (CDE)/Data Standards Webinar Series on January 28, 2026.

This interactive monthly series will highlight current efforts in preclinical CDEs and data standards. Speakers from the NT-PRECEDS Program and invited experts will share best practices, tools, and resources to help harmonize and strengthen preclinical research.

Topics will include:
- Experimental design, rigor, and reproducibility
- Metadata, data repositories, and best practices for data sharing
- Injury models, EEG and seizures, biomarkers, and -omics
- Histopathology, imaging, and related data standards

The series supports FAIR and TRUST data sharing principles and aligns with the NIH Strategic Plan and Data Management and Sharing Policy—aiming to improve reproducibility and cross-study analysis.

The webinars are free and open to the public.

Register here to receive invitations and access recordings: https://bit.ly/4bg7N85
Questions? Contact Dr. Claudio Villalobos Dintrans at [email protected].